Recent health developments range from advancements in chronic disease treatments and digital monitoring technology to regulatory updates and safety concerns in fertility care.
Key Points
The biological drug tezepelumab has demonstrated potential clinical benefits for patients suffering from eosinophilic esophagitis (EoE).
Patients with relapsed or refractory B-cell acute lymphoblastic leukemia (B-ALL) experienced lower rates of sinusoidal obstruction syndrome when treated with InO combined with defibrotide before undergoing HSCT.
A novel machine-learning powered wrist-worn wearable has proven more accurate than traditional clinical assessments in tracking upper-limb recovery for stroke patients.
The UK Medicines and Healthcare products Regulatory Agency (MHRA) is mandating more prominent suicide warnings on antidepressant leaflets and introducing new patient information cards.
The Human Fertilisation and Embryology Authority (HFEA) reported a 19 percent increase in safety incidents and near misses within fertility clinics over the past year.
A new compounded prescription nasal spray containing vardenafil is now available in the United States as an alternative treatment option for erectile dysfunction.
A remotely supervised high-intensity interval training (HIIT) program has been found to significantly improve cardiorespiratory fitness in youth diagnosed with postinfectious bronchiolitis obliterans.
A new study clarifies that while gold allergies are common among dermatitis patients, they do not correlate with an increased risk of developing autoimmune diseases.